北京血尿酸高一定会痛风吗-【好大夫在线】,tofekesh,济南尿酸高能不能治好,山东痛风要怎么缓解疼痛,济南痛风结晶溶解会一直疼,济南有什么办法治痛风石,济南痛风可以喝什么汤,济南痛风应该吃什么菜
北京血尿酸高一定会痛风吗北京经常吃海鲜会痛风吗,济南有什么好的方法治痛风,山东尿酸高能说明什么,山东苏打片治痛风吗,济南治疗痛风比较好方法,山东痛风怎样调理,济南脚踝痛风的症状有哪些
SAN DIEGO (KGTV) - With the cost of living going up in San Diego, a lot of people are looking for ways to make extra cash. A new startup in San Diego called Bounce wants to help drivers maximize their income. "The drivers are the most important element," said CEO Mark Potter. Potter transformed the front of his law office into the startup space. He is a longtime fan of rideshare. "Before there was rideshare, I was hiring people off craigslist to give me rides," Potter said.His model for this new company is to focus on the driver and give them more incentives to want to stay and work for the company. "Our drivers are owners. They earn ownership in our company through stock options," said Potter. This stake in the company is one of the main reasons Pamela Bernier signed on to be a driver. Bernier said, "Working my own hours, calling my own shots, still enjoying the income and the people at the same time."Bounce also has a repeat customer option. Riders have the freedom to create a list and request their favorite drivers. They also have the luxury to arrange future rides in advance. According to the company, this provides a safer environment for both the rider and driver and also gives the driver a more consistent cash flow. "I could bounce you here, I can bounce you there, I bounce you home, where you wanna bounce let's go," said Bernier. Uber and Lyft are two other companies dominating the rideshare space. According to Lyft, 68% of drivers are primary earners of their household, and so far in 2018, Lyft passengers also spent an additional million on local businesses in town. According to Uber, rideshare and delivery drivers in California took home more than .97 billion in gross revenue for 2017. Bounce is set for a September launch, and the company is currently interviewing drivers. They require in-person interviews and background checks for each driver. They are also in the process of putting in a panic button option in the app for riders to feel safer during their ride. "We envision is that our company will be very successful with loyal drivers that put Bounce first. That will make us win," Potter said. 2247
SAN DIEGO (KGTV) -- Traffic was backed up throughout the day Monday in Clairemont after a crash involving several vehicles. The crash happened just before 1 p.m. on Balboa Avenue near Albertine Avenue. According to San Diego Police, a 59-year-old man driving west on Balboa Avenue hit a raised median and crossed into the eastbound lanes of traffic. Police say he then hit a Jeep Patriot, causing it to slam into a Honda Civic and a Jeep Cherokee. Police say the driver of the Jeep Patriot sustained a fractured femur and was taken to the hospital. Her passenger also complained of pain. No one else was injured. The 59-year-old driver of the Nissan Frontier was arrested for DUI drugs. 695
SAN DIEGO (KGTV) - While still a few years away from breaking ground, San Diego's Central Embarcadero will be getting a major facelift.On Tuesday Protea Waterfront Development updated the Port of San Diego on their most recent proposed changes: 252
SAN DIEGO (KGTV) -- You can add San Diego to the list of places where a mysterious metal monolith has popped up.The mysterious object was spotted earlier this week at the Scripps Ranch Marketplace shopping center on Scripps Poway Parkway.As word of the monolith spread on social media, many people gathered around the object to take photos.There is no word on how the monolith got to the shopping center, but it has since been removed as of Wednesday morning.ABC 10News learned a social media video shows a group of teens removing the monolith and carrying it away. 573
SAN DIEGO (KGTV) — When you are out in public, it is virtually impossible to tell who has immunity to the coronavirus and who is susceptible.A San Diego-based company is trying to change that by developing two new COVID-19 monitoring systems that are as easy as checking someone’s forearm.Diomics is developing a device that looks like a nicotine patch that the company says can reveal the presence of SARS-CoV-2 antibodies in 24 to 36 hours. The patch is intended to be worn for one to two weeks, offering people a way to monitor -- and potentially display -- their infection status, according to CEO Anthony Zolezzi.When the patch, named Diocheck, detects antibodies circulating in the blood, it turns red.“We think this is an integral piece of getting things back to normal,” Zolezzi said. “This can get the country back operating and get us comfortable that the people around us aren’t infected.”A second device, made from thousands of tiny polymer beads, can be injected into the skin and offer COVID monitoring for six months to a year, Zolezzi said. The company is still testing how long the test can stay active before it’s safely absorbed by the body.The company plans to launch clinical trials at UC Irvine next month.Zolezzi envisions the tests would be useful for employees in numerous sectors, including the airline industry, the cruise industry, the gambling industry and the military, offering a new way to detect and rapidly quarantine infected individuals.Once a coronavirus vaccine is released, the tests could be a useful companion, he said, since it will likely take several weeks to develop protective antibodies after inoculation. An individual wearing the patch, for example, could find out when they have antibodies circulating in the blood.The tests could also show when a person begins to lose antibodies. Studies have show individuals with a mild coronavirus infection lose antibodies after a few months, and it’s common for vaccines to require multiple doses.“This patch will show you, when the color dissipates, it’s because your antibodies have dissipated,” Zolezzi said. “That’s the time when you need to get a boost, or some type of prophylaxis.”The small biotech firm with less than 20 employees is leveraging technology that’s more than 100 years old.In 1907, a French physician named Charles Mantoux developed an injection test for tuberculosis that produces a raised, red dot on the skin when the bacteria is detected. This is the standard test given today.“All we’re doing is modernizing it,” Zolezzi said. The company’s patented slow-release material allows for much longer monitoring, he added.Diomics was making skin care, wound care and diabetes products before the pandemic shifted the company’s focus. Their components are FDA approved individually, but will need new approval for this use, Zolezzi said.Zolezzi said production is underway, but the company is hoping to partner with a large drugmaker to rapidly scale up manufacturing. Their goal is to have products on the market by the end of the year. 3055